152 related articles for article (PubMed ID: 31267008)
1. Design and applications of gene therapy vectors for mucopolysaccharidosis in Colombia.
Alméciga-Diaz CJ; Barrera LA
Gene Ther; 2020 Feb; 27(1-2):104-107. PubMed ID: 31267008
[TBL] [Abstract][Full Text] [Related]
2. Adeno-associated viral gene therapy for mucopolysaccharidoses exhibiting neurodegeneration.
Lau AA; Hemsley KM
J Mol Med (Berl); 2017 Oct; 95(10):1043-1052. PubMed ID: 28660346
[TBL] [Abstract][Full Text] [Related]
3. Gene therapy for neurologic manifestations of mucopolysaccharidoses.
Wolf DA; Banerjee S; Hackett PB; Whitley CB; McIvor RS; Low WC
Expert Opin Drug Deliv; 2015 Feb; 12(2):283-96. PubMed ID: 25510418
[TBL] [Abstract][Full Text] [Related]
4. Gene Therapy for Neuronopathic Mucopolysaccharidoses: State of the Art.
de Castro MJ; Del Toro M; Giugliani R; Couce ML
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502108
[TBL] [Abstract][Full Text] [Related]
5. Gene therapies for mucopolysaccharidoses.
Rossi A; Brunetti-Pierri N
J Inherit Metab Dis; 2024 Jan; 47(1):135-144. PubMed ID: 37204267
[TBL] [Abstract][Full Text] [Related]
6. Nanotechnology applied to treatment of mucopolysaccharidoses.
Schuh RS; Baldo G; Teixeira HF
Expert Opin Drug Deliv; 2016 Dec; 13(12):1709-1718. PubMed ID: 27322551
[TBL] [Abstract][Full Text] [Related]
7. Ex Vivo and In Vivo Gene Therapy for Mucopolysaccharidoses: State of the Art.
Consiglieri G; Bernardo ME; Brunetti-Pierri N; Aiuti A
Hematol Oncol Clin North Am; 2022 Aug; 36(4):865-878. PubMed ID: 35773049
[TBL] [Abstract][Full Text] [Related]
8. [Construction of an adenoassociated, viral derived, expression vector to correct the genetic defect in Morquio A disease].
Gutiérrez MA; García-Vallejo F; Tomatsu S; Cerón F; Alméciga-Díaz CJ; Domínguez MC; Barrera LA
Biomedica; 2008 Sep; 28(3):448-59. PubMed ID: 19034368
[TBL] [Abstract][Full Text] [Related]
9. Gene therapy for mucopolysaccharidosis.
Ponder KP; Haskins ME
Expert Opin Biol Ther; 2007 Sep; 7(9):1333-45. PubMed ID: 17727324
[TBL] [Abstract][Full Text] [Related]
10. Emerging drugs for the treatment of mucopolysaccharidoses.
Giugliani R; Federhen A; Vairo F; Vanzella C; Pasqualim G; da Silva LM; Giugliani L; de Boer AP; de Souza CF; Matte U; Baldo G
Expert Opin Emerg Drugs; 2016; 21(1):9-26. PubMed ID: 26751109
[TBL] [Abstract][Full Text] [Related]
11. Treatment of brain disease in the mucopolysaccharidoses.
Scarpa M; Orchard PJ; Schulz A; Dickson PI; Haskins ME; Escolar ML; Giugliani R
Mol Genet Metab; 2017 Dec; 122S():25-34. PubMed ID: 29153844
[TBL] [Abstract][Full Text] [Related]
12. Mucopolysaccharidosis type IVA (Morquio A disease): clinical review and current treatment.
Tomatsu S; Montaño AM; Oikawa H; Smith M; Barrera L; Chinen Y; Thacker MM; Mackenzie WG; Suzuki Y; Orii T
Curr Pharm Biotechnol; 2011 Jun; 12(6):931-45. PubMed ID: 21506915
[TBL] [Abstract][Full Text] [Related]
13. Current and potential therapeutic strategies for mucopolysaccharidoses.
Noh H; Lee JI
J Clin Pharm Ther; 2014 Jun; 39(3):215-24. PubMed ID: 24612142
[TBL] [Abstract][Full Text] [Related]
14. A Case Report of a Japanese Boy with Morquio A Syndrome: Effects of Enzyme Replacement Therapy Initiated at the Age of 24 Months.
Nakamura-Utsunomiya A; Nakamae T; Kagawa R; Karakawa S; Sakata S; Sakura F; Tani C; Matsubara Y; Ishino T; Tajima G; Okada S
Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32024277
[TBL] [Abstract][Full Text] [Related]
15. Therapy for the mucopolysaccharidoses.
Valayannopoulos V; Wijburg FA
Rheumatology (Oxford); 2011 Dec; 50 Suppl 5():v49-59. PubMed ID: 22210671
[TBL] [Abstract][Full Text] [Related]
16. Gene delivery strategies for the treatment of mucopolysaccharidoses.
Baldo G; Giugliani R; Matte U
Expert Opin Drug Deliv; 2014 Mar; 11(3):449-59. PubMed ID: 24450877
[TBL] [Abstract][Full Text] [Related]
17. Gene therapy for mucopolysaccharidoses: in vivo and ex vivo approaches.
Fraldi A; Serafini M; Sorrentino NC; Gentner B; Aiuti A; Bernardo ME
Ital J Pediatr; 2018 Nov; 44(Suppl 2):130. PubMed ID: 30442177
[TBL] [Abstract][Full Text] [Related]
18. Phase I and II clinical trials for the mucopolysaccharidoses.
Poswar F; Baldo G; Giugliani R
Expert Opin Investig Drugs; 2017 Dec; 26(12):1331-1340. PubMed ID: 29065735
[TBL] [Abstract][Full Text] [Related]
19. Gene therapy for Mucopolysaccharidoses.
Sawamoto K; Chen HH; Alméciga-Díaz CJ; Mason RW; Tomatsu S
Mol Genet Metab; 2018 Feb; 123(2):59-68. PubMed ID: 29295764
[TBL] [Abstract][Full Text] [Related]
20. [Mucopolysaccharidosis: clinical features, diagnosis and management].
Suarez-Guerrero JL; Gómez Higuera PJ; Arias Flórez JS; Contreras-García GA
Rev Chil Pediatr; 2016; 87(4):295-304. PubMed ID: 26613630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
